| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/03/2026 | ±2.9% | -0.2% | over-priced |
| 08/03/2026 | ±2.9% | -0.2% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $3.48 | $116.0B | $14.5B |
| Q2 FY2025 | $1.64 | $81.5B | $7.1B |
XOM (XOM) reports in 6 days, with the next report estimated for 11/02/2026. Across the last 2 reports, options priced an average ±2.9% earnings move while the stock actually moved 0.2% on average — the market has systematically over-priced XOM's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue up 0.0%. QuantLogix's live 5-factor engine currently reads XOM as a buy at 89/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →